599 filings
SC 13G/A
SYRE
Spyre Therapeutics Inc.
23 Apr 24
Spyre Therapeutics / Avoro Capital Advisors ownership change
6:22pm
S-1
SYRE
Spyre Therapeutics Inc.
IPO registration
18 Apr 24
8:24pm
ARS
2023 FY
SYRE
Spyre Therapeutics Inc.
2 Apr 24
Annual report to shareholders
4:36pm
EFFECT
SYRE
Spyre Therapeutics Inc.
2 Apr 24
Notice of effectiveness
12:15am
EFFECT
SYRE
Spyre Therapeutics Inc.
2 Apr 24
Notice of effectiveness
12:15am
POS AM
lclrct48 94ufc
26 Mar 24
Prospectus update (post-effective amendment)
6:30pm
424B3
osx 4gknfeyghm
18 Mar 24
Prospectus supplement
4:06pm
8-K
80hsm
18 Mar 24
Spyre Therapeutics Announces $180 Million Private Placement
8:31am
POS AM
3txh6zr stn76bj0
14 Mar 24
Prospectus update (post-effective amendment)
4:12pm
SC 13G/A
cpobfnd
11 Mar 24
Spyre Therapeutics / FMR ownership change
8:19am
POS AM
f2vwebe0rk2m 9oex
5 Mar 24
Prospectus update (post-effective amendment)
5:15pm
S-8
x0kddckb
29 Feb 24
Registration of securities for employees
5:06pm
8-K
0hr5wnpgkdfpd oxmgu
29 Feb 24
Spyre Therapeutics Reports Fourth Quarter and Full Year 2023 Financial Results and Provides Corporate Update
4:14pm
4
5c2wsqldkqw8nvsa
20 Feb 24
Spyre Therapeutics / Cameron Turtle ownership change
9:21pm